• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARJOHUNTLEIGH, INC. ROTOPRONE; BED, PATIENT ROTATION, POWERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARJOHUNTLEIGH, INC. ROTOPRONE; BED, PATIENT ROTATION, POWERED Back to Search Results
Model Number 209500
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pressure Sores (2326)
Event Date 05/20/2020
Event Type  Injury  
Manufacturer Narrative
Please note that previous medwatch reports for this product may have been submitted under the following registration numbers: 1625774, 3010048749, 3009988881, 3007420694.Currently, this product is to be handled by arjohuntleigh ab¿s complaint handling establishment and any medwatch reports will be submitted under registration 9681684.A supplemental report will be provided once investigation conclusions are available.
 
Event Description
A customer reported that a patient developed blister to bilateral breasts, blister to left anterior knee, deep tissue injury to bilateral shins, and pressure injury to bilateral facial/cheeks while using a rotoprone bed.Patient was placed on the rotoprone bed on (b)(6) 2020 and the bilateral breast blisters were assessed on (b)(6) 2020, the left anterior knee blister was assessed on (b)(6) 2020, the bilateral shin deep tissue injury was assessed on (b)(6) 2020 and the bilateral facial/cheeks pressure injury was assessed on (b)(6) 2020.Patient was removed from the bed on (b)(6) 2020, and passed away on (b)(6) 2020.The cause of death was acute respiratory failure due to covid-19.
 
Manufacturer Narrative
Arjo received a mdr report from the fda # (b)(4), which was submitted by the customer through the fda¿s medical product safety network (medsun) program.Because report did not suggest that an adverse event has occurred or that an arjo device caused or contributed to the reported event, we contacted the customer to obtain detailed information.On november 24, 2020, arjo became aware that patient sustained blister to bilateral breasts, blister to left anterior knee, deep tissue injury to bilateral shins, and pressure injury to bilateral facial/cheeks while using a rotoprone bed, which was assessed as serious injury.The patient was placed on the rotoprone bed on (b)(6) 2020 and the bilateral breast blisters were assessed on (b)(6) 2020, the left anterior knee blister was assessed on (b)(6) 2020, the bilateral shin deep tissue injury was assessed on (b)(6) 2020 and the bilateral facial/cheeks pressure injury was assessed on(b)(6) 2020.Patient was removed from the bed on (b)(6) 2020, and passed away on (b)(6) 2020.The cause of death was acute respiratory failure due to covid-19.According to customer¿s medical records, the patient was prone for 9 hours and supine for 3 hour, the patient was rotating side to side, the patient was wearing bilateral scds, the patient was not diaphoretic and the injuries looked like a blister, the ett was secured with cloth tape.The patient was diagnosised with acute respiraoty failure due to covid-19.No additional information such as how the injuries occurred was available.As part of the investigation, we reviewed relevant arjo service records.The bed in question returned from rent on june 6, 2020.The next day the quality control check was completed at arjo.There was no repair completed, the bed was functioning correctly.On june 9, 2020 the bed was rented again by the same customer.From the reviewed information, arjo concluded that the reported event was potentially related to patient¿s existing medical conditions.A patient who is placed on a rotoprone bed is in a life-threatening situation physically, critically ill and typically is intubated, ventilated and sedated often with multiple co-morbidities.This patient profile is particularly vulnerable to skin ulcers/skin breakdown.There was no product failure.The rotoprone instructions for use (ifu) include warnings and precautions regarding skin care: ¿skin care ¿ fitting the head support, face pack, proning packs or other accessory packs too tightly may increase pressure points, possibly leading to skin breakdown.Assess skin at frequent intervals depending on patient condition (at least once every four hours).Give extra attention to skin at pressure points and locations where moisture or incontinence may occur or collect.Common pressure points include, but are not limited to, the face, ears, axilla, shoulders, sides and upper and lower extremities.Early intervention may be essential to preventing serious skin breakdown.Do not leave patient in a stationary position in the supine or prone position for more than two hours.¿ in summary, rotoprone bed was used for a patient treatment when a serious injury was noticed and therefore played a role in the event.But there was no device failure, the device met manufacturer's specification.We report this event following information that the patient sustained serious skin injury during therapy on rotoprone.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTOPRONE
Type of Device
BED, PATIENT ROTATION, POWERED
Manufacturer (Section D)
ARJOHUNTLEIGH, INC.
4958 stout drive
san antonio TX 78219
MDR Report Key11054576
MDR Text Key241252810
Report Number9681684-2020-00084
Device Sequence Number1
Product Code IKZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Type of Report Initial,Followup
Report Date 01/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number209500
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 11/24/2020
Initial Date FDA Received12/22/2020
Supplement Dates Manufacturer Received11/24/2020
Supplement Dates FDA Received01/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-